For the first six months of 2013 Pharmaceutical company "Stirolbiofarm" (Gorlovka, Donetsk region). Sold goods worth a total of 70.6 million hryvnia, compared with the same period last year is 133.9%.
EBITDA amounted to 28.9 mln., Compared with the corresponding period in 2012 was 184.6%. Cash flow from operating activities amounted to 22.3 mln. The increase in capital expenditures amounted to 161.2%.
The company "Stirolbiofarm" was registered as a limited liability company specializing in the manufacture of medicines and dietary supplements. The company has been operating since 1996 and is a supplier of solid, liquid and gaseous forms of drugs in the domestic and overseas markets.